Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversal of malignant ADAR1 splice isoform switching with Rebecsinib
Leslie Crews, Wenxue Ma, Luisa Ladel, et al.
Cell stem cell (2023) Vol. 30, Iss. 3, pp. 250-263.e6
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 68
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16
ADAR1: from basic mechanisms to inhibitors
Jan Rehwinkel, Parinaz Mehdipour
Trends in Cell Biology (2024)
Open Access | Times Cited: 11
A Wonderful Journey: The Diverse Roles of Adenosine Deaminase Action on RNA 1 (ADAR1) in Central Nervous System Diseases
Lin Cheng, Ziying Liu, Chunxiao Shen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Stem-Cell Aging and Pathways to Precancer Evolution
Catriona Jamieson, Irving L. Weissman
New England Journal of Medicine (2023) Vol. 389, Iss. 14, pp. 1310-1319
Closed Access | Times Cited: 19
ADAR Family Proteins: A Structural Review
Carolyn N. Ashley, Emmanuel Broni, Whelton A. Miller
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 3919-3945
Open Access | Times Cited: 8
Structural–functional diversity of CD47 proteoforms
Ting Zhang, Feng Wang, Lu Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Flipons and small RNAs accentuate the asymmetries of pervasive transcription by the reset and sequence-specific microcoding of promoter conformation
Alan Herbert
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105140-105140
Open Access | Times Cited: 14
Zα and Zβ Localize ADAR1 to Flipons That Modulate Innate Immunity, Alternative Splicing, and Nonsynonymous RNA Editing
Alan Herbert, Oleksandr Cherednichenko, Terry P. Lybrand, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2422-2422
Open Access
ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer
Hibiki Umeda, Kunitoshi Shigeyasu, Toshiaki Takahashi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
3D insights: JAK2 46/1 haplotype shapes MPN development
Inge van der Werf, Catriona Jamieson
Blood (2025) Vol. 145, Iss. 19, pp. 2112-2114
Closed Access
Epitranscriptomic subtyping, visualization, and denoising by global motif visualization
Jianheng Liu, Tao Huang, Jing Yao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
Scott S. Auerbach, Beana Puka, Upendarrao Golla, et al.
Life (2024) Vol. 14, Iss. 3, pp. 309-309
Open Access | Times Cited: 2
Non‐m6A RNA modifications in haematological malignancies
Meiling Chen, Yuanzhong Chen, Kitty Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 2
Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets
Hao Cheng, Jun Yu, Chi Chun Wong
Protein & Cell (2024)
Open Access | Times Cited: 2
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, et al.
Aspects of Molecular Medicine (2023) Vol. 2, pp. 100023-100023
Open Access | Times Cited: 5
High-throughput virtual screening to identify potential small molecule inhibitors of the Zα domain of the adenosine deaminases acting on RNA 1(ADAR1)
Xiaoshan Hong, Zhifu Wei, Lulu He, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 193, pp. 106672-106672
Open Access | Times Cited: 5
Role of RNA modifications in blood development and regeneration
Rajesh D. Gunage, Leonard I. Zon
Experimental Hematology (2024) Vol. 138, pp. 104279-104279
Closed Access | Times Cited: 1
RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code
Inge van der Werf, Jenna S Sneifer, Catriona Jamieson
FEBS Letters (2024)
Open Access | Times Cited: 1
Navigating the landscape of epitranscriptomics and host immunity
Elaine Huang, Clara Frydman, Xinshu Xiao
Genome Research (2024)
Open Access | Times Cited: 1
ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer
Yanara A Bernal, Eduardo Durán-Jara, Isidora Solar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7424-7424
Open Access | Times Cited: 1
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy
Jinze Shen, Jianqiao Shentu, Chenming Zhong, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 1
Generation of tumor neoantigens by RNA splicing perturbation
Adi Rosenberg-Mogilevsky, Zahava Siegfried, Rotem Karni
Trends in cancer (2024)
Closed Access | Times Cited: 1
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
Lindsey Murphy, Amanda Winters
(2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top